Obsidian Therapeutics to Participate in Citi’s 17th Annual BioPharma Conference 2022
September 6, 2022Read More
MD Anderson and Obsidian Therapeutics announce FDA Clearance of IND application for novel TIL therapy OBX-115
July 21, 2022Read More
Join Our Team
Join our collaborative team of innovators who are motivated by a sense of urgency to help patients in need.
Our collective knowledge, capabilities, intellect and energy is our greatest strength.